Clinical trial
A Comparison of PLAtelet Response to Aspirin Between Emergency Department Patients With Chest Pain Receiving Fentanyl or Morphine (PLAAFM)
NCT05367336 is registered in ClinicalTrials.gov with Corewell Health South as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of PLAtelet Response to Aspirin Between Emergency Department Patients With Chest Pain Receiving Fentanyl or Morphine (PLAAFM)
- Lead sponsor
- Corewell Health South
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 31, 2022
- Completion date
- February 18, 2025
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fentanyl, platelet reactivity